146 related articles for article (PubMed ID: 1832369)
1. In vitro antibacterial activity of trospectomycin (U-63,366F) against anaerobic bacteria and aerobic gram-positive cocci in Chile.
Montiel F; Kaltwasser G; Pinto ME; Lam M
Diagn Microbiol Infect Dis; 1991; 14(3):259-64. PubMed ID: 1832369
[TBL] [Abstract][Full Text] [Related]
2. The in vitro activity of trospectomycin against anaerobic bacteria.
Chisari G; Lo Bue AM; Nicoletti G
J Chemother; 1995 Dec; 7(6):515-8. PubMed ID: 8667035
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity against aerobes and anaerobes of trospectomycin versus spectinomycin.
Gismondo MR; Chisari G; Lo Bue AM
Drugs Exp Clin Res; 1991; 17(2):101-4. PubMed ID: 1830841
[TBL] [Abstract][Full Text] [Related]
4. Activity of trospectomycin against Bacteroides fragilis and other Bacteroides species.
Jacobus NV; Tally FP
Antimicrob Agents Chemother; 1988 Apr; 32(4):584-6. PubMed ID: 2967671
[TBL] [Abstract][Full Text] [Related]
5. Susceptibility of 539 gram-positive and gram-negative anaerobes to new agents, including RP59500, biapenem, trospectomycin and piperacillin/tazobactam.
Appelbaum PC; Spangler SK; Jacobs MR
J Antimicrob Chemother; 1993 Aug; 32(2):223-31. PubMed ID: 8226424
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of a new antibacterial drug, trospectomycin sulphate (U-63,366F), against Bacteroides strains isolated from the vagina.
Testore GP; Terranova L; Salanitro A; Sordillo P; Foli A; Giacomello F; Andreoni M
Chemotherapy; 1993; 39(2):124-7. PubMed ID: 8458245
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of trospectomycin (U-63366F), a novel spectinomycin analog, against gram-positive isolates from cancer patients.
Rolston K; Ho DH; Bodey GP
Eur J Clin Microbiol Infect Dis; 1989 Mar; 8(3):254-60. PubMed ID: 2523806
[TBL] [Abstract][Full Text] [Related]
8. [Antimicrobial susceptibility of clinical isolates of aerobic Gram-positive cocci and anaerobic bacteria in 2006].
Yamaguchi T; Yoshida I; Itoh Y; Tachibana M; Takahashi C; Kaku M; Kanemitsu K; Okada M; Horikawa Y; Shiotani J; Kino H; Ono Y; Baba H; Matsuo S; Asari S; Toyokawa M; Matsuoka K; Kusano N; Nose M; Murase M; Miyamoto H; Saikawa T; Hiramatsu K; Kohno S; Yanagihara K; Yamane N; Nakasone I; Maki H; Yamano Y
Jpn J Antibiot; 2010 Dec; 63(6):431-56. PubMed ID: 21425596
[TBL] [Abstract][Full Text] [Related]
9. [Antimicrobial susceptibility of clinical isolates of aerobic gram-positive cocci and anaerobic bacteria in 2008].
Yoshida I; Yamaguchi T; Kudo R; Fuji R; Takahashi C; Oota R; Kaku M; Kunishima H; Okada M; Horikawa Y; Shiotani J; Kino H; Ono Y; Fujita S; Matsuo S; Kono H; Asari S; Toyokawa M; Kusano N; Nose M; Horii T; Tanimoto A; Miyamoto H; Saikawa T; Hiramatsu K; Kohno S; Yanagihara K; Yamane N; Nakasone I; Maki H; Yamano Y
Jpn J Antibiot; 2012 Feb; 65(1):49-72. PubMed ID: 22808693
[TBL] [Abstract][Full Text] [Related]
10. In vitro antibacterial activity of trospectomycin (U-63366F), a novel spectinomycin analog.
Zurenko GE; Yagi BH; Vavra JJ; Wentworth BB
Antimicrob Agents Chemother; 1988 Feb; 32(2):216-23. PubMed ID: 2966608
[TBL] [Abstract][Full Text] [Related]
11. In vitro activities of dalbavancin and 12 other agents against 329 aerobic and anaerobic gram-positive isolates recovered from diabetic foot infections.
Goldstein EJ; Citron DM; Warren YA; Tyrrell KL; Merriam CV; Fernandez HT
Antimicrob Agents Chemother; 2006 Aug; 50(8):2875-9. PubMed ID: 16870792
[TBL] [Abstract][Full Text] [Related]
12. In vitro susceptibilities of oral pigmented Bacteroides species to trospectomycin and other selected antimicrobial agents.
Johnson CC; Wendeler M; Levison ME
Antimicrob Agents Chemother; 1990 Aug; 34(8):1597-9. PubMed ID: 2145801
[TBL] [Abstract][Full Text] [Related]
13. Comparative in vitro activities of SMT19969, a new antimicrobial agent, against Clostridium difficile and 350 gram-positive and gram-negative aerobic and anaerobic intestinal flora isolates.
Goldstein EJ; Citron DM; Tyrrell KL; Merriam CV
Antimicrob Agents Chemother; 2013 Oct; 57(10):4872-6. PubMed ID: 23877700
[TBL] [Abstract][Full Text] [Related]
14. [The study of drug resistance in aerobic and anaerobic bacterial flora to selected antibacterial drugs].
Michalska W; Chylak J; Pietkiewicz K
Med Dosw Mikrobiol; 1996; 48(1-2):61-70. PubMed ID: 8926770
[TBL] [Abstract][Full Text] [Related]
15. Antibacterial activity of trospectomycin (U-63366F) and initial evaluations of disk diffusion susceptibility tests.
Barry AL; Jones RN; Thornsberry C
Antimicrob Agents Chemother; 1989 Apr; 33(4):569-72. PubMed ID: 2524997
[TBL] [Abstract][Full Text] [Related]
16. Antibacterial effect of imipenem in vitro against important aerobic and anaerobic strains isolated from clinical specimens.
Klietmann W; Focht J; Nösner K
Chemioterapia; 1987 Aug; 6(4):243-50. PubMed ID: 3477332
[TBL] [Abstract][Full Text] [Related]
17. Trospectomycin enhances surface phagocytosis of Bacteroides and Staphylococcus by altering the bacterial glycocalyx.
Veringa EM; Ferguson DA; Lambe DW; Verhoef J
Zentralbl Bakteriol; 1989 Sep; 271(3):311-20. PubMed ID: 2529862
[TBL] [Abstract][Full Text] [Related]
18. Comparative in vitro beta-lactam activity against aerobic and anaerobic surgical isolates.
Edmiston CE; Krepel CJ; Clausz JC; Condon RE
Diagn Microbiol Infect Dis; 1988 Feb; 9(2):105-13. PubMed ID: 3164263
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial susceptibility of anaerobic and aerobic bacteria isolated from patients with mixed infections in Nicaragua.
Cáceres M; Carrera E; Palma A; Berrios G; Weintraub A; Nord CE
Rev Esp Quimioter; 1999 Dec; 12(4):332-9. PubMed ID: 10855012
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of MDL 62,879 (GE2270 A) against aerobic gram-positive and anaerobic bacteria.
King A; Bethune L; Phillips I
Antimicrob Agents Chemother; 1993 Apr; 37(4):746-9. PubMed ID: 8494370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
